Complete remission of critical neurohistiocytosis by vemurafenib

Complete remission of critical neurohistiocytosis by vemurafenib

Bibliographic Details
Main Authors:	Euskirchen, Philipp, Haroche, Julien, Emile, Jean-François, Buchert, Ralph, Vandersee, Staffan, Meisel, Andreas
Format:	Online
Language:	English
Published:	Lippincott Williams & Wilkins 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345630/

Similar Items

Targeted treatment of brainstem neurohistiocytosis guided by urinary cell-free DNA
by: Hunt, David, et al.
Published: (2016)

Excellent response of intramedullary Erdheim-Chester disease to vemurafenib: a case report
by: Tzoulis, Charalampos, et al.
Published: (2015)

Scurvy in a patient on vemurafenib
by: Gerstenblith, Meg R., et al.
Published: (2014)

Metastatic melanoma and vemurafenib: novel approaches
by: De Mello, Ramon Andrade
Published: (2012)

A STATement on Vemurafenib-Resistant Melanoma
by: Hartsough, Edward J., et al.
Published: (2013)

Complete remission of locally adComplete remission of locally advanced penile squamous cell carcinoma after multimodality treatment
by: Yifan Meng, et al.
Published: (2016-12-01)

Complete Remission in Metastatic Pheochromocytoma Treated with Extensive Surgery
by: Arnas-Leon, Claudia, et al.
Published: (2016)

Vemurafenib and cutaneous adverse events - report of five cases*
by: Silva, Giselle de Barros, et al.
Published: (2015)

Correction: RASopathic Skin Eruptions during Vemurafenib Therapy
by: Rinderknecht, Jeannine D., et al.
Published: (2013)

Safety and efficacy of vemurafenib in end stage renal failure
by: Iddawela, Mahesh, et al.
Published: (2013)

RASopathic Skin Eruptions during Vemurafenib Therapy
by: Rinderknecht, Jeannine D., et al.
Published: (2013)

Managing Side Effects of Vemurafenib Therapy for Advanced Melanoma
by: Hagen, Brenda, et al.
Published: (2014)

DNA repair inhibition by UVA photoactivated fluoroquinolones and vemurafenib
by: Peacock, Matthew, et al.
Published: (2014)

Long Term Survival and Continued Complete Response of Vemurafenib in a Metastatic Melanoma Patient with BRAF V600K Mutation
by: Sahadudheen, K., et al.
Published: (2016)

Blue-Violet Light Irradiation Dose Dependently Decreases Carotenoids in Human Skin, Which Indicates the Generation of Free Radicals
by: Vandersee, Staffan, et al.
Published: (2015)

Towards achieving remission in the treatment of depression
by: Mendlewicz, Julien
Published: (2008)

Familial Mediterranean Fever With Complete Symptomatic Remission During Pregnancy
by: Kim, Kwang Taek, et al.
Published: (2015)

Case analysis of complete remission of advanced hepatocellular carcinoma achieved with sorafenib
by: Liu, Daizhong, et al.
Published: (2015)

Complete Remission of Anaplastic Thyroid Carcinoma after Concomitant Treatment with Docetaxel and Radiotherapy
by: Abe, Ichiro, et al.
Published: (2015)

Complete Remission of Generalized Myasthenia Gravis by Corticosteroid Treatment Alone without Thymectomy
by: Kataoka, Hiroshi, et al.
Published: (2011)

Complete Long-Term Remission of an Inflammatory Pseudotumor under Corticosteroid Therapy
by: Pfeifer, Lukas, et al.
Published: (2011)

Complete remission of pulmonary metastases of Bellini duct carcinoma with cisplatin, gemcitabine and bevacizumab
by: Barrascout, Eduardo, et al.
Published: (2012)

Complete remission of coronary vasculitis in Churg–Strauss Syndrome by prednisone and cyclophosphamide
by: Riksen, Niels P., et al.
Published: (2010)

Intradermal influenza vaccination in complete remission cancer patients: molecular insights
by: Bedognetti, Davide, et al.
Published: (2013)

Early Complete Remission of Osteoid Osteoma with Conservative Medical Management
by: Yokouchi, Masahiro, et al.
Published: (2014)

Complete remission with tyrosine kinase inhibitors in renal cell carcinoma
by: Wada, Yoshihiro, et al.
Published: (2012)

Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor
by: Aylwin, Simon J. B., et al.
Published: (2015)

Vemurafenib: First-in-Class BRAF-Mutated Inhibitor for the Treatment of Unresectable or Metastatic Melanoma
by: Shelledy, Lindsay, et al.
Published: (2015)

Vemurafenib resistance reprograms melanoma cells towards glutamine dependence
by: Hernandez-Davies, Jenny E, et al.
Published: (2015)

Dupuytren’s contractures associated with the BRAF inhibitor vemurafenib: a case report
by: Chan, Sze Wai, et al.
Published: (2015)

Clinical results of combined vemurafenib and tumor-infiltrating lymphocyte therapy for metastatic melanoma
by: Sarnaik, Amod, et al.
Published: (2015)

mTOR inhibitors sensitize thyroid cancer cells to cytotoxic effect of vemurafenib
by: Hanly, Elyse K., et al.
Published: (2015)

Corticosteroids Augment BRAF Inhibitor Vemurafenib Induced Lymphopenia and Risk of Infection
by: Sondermann, Wiebke, et al.
Published: (2015)

Inhibition of vemurafenib-resistant melanoma by interference with pre-mRNA splicing
by: Salton, Maayan, et al.
Published: (2015)

Trametinib with or without Vemurafenib in BRAF Mutated Non-Small Cell Lung Cancer
by: Joshi, Monika, et al.
Published: (2015)

Vemurafenib: a new treatment for BRAF-V600 mutated advanced melanoma
by: Fisher, Rosalie, et al.
Published: (2012)

Spontaneous splenic rupture in patient with metastatic melanoma treated with vemurafenib
by: Castellani, Elisa, et al.
Published: (2012)

Vemurafenib: an evidence-based review of its clinical utility in the treatment of metastatic melanoma
by: Swaika, Abhisek, et al.
Published: (2014)

Vemurafenib enhances MHC induction in BRAFV600E homozygous melanoma cells
by: Sapkota, Bishu, et al.
Published: (2013)

Orbital and chorioretinal manifestations of Erdheim-Chester disease treated with vemurafenib
by: Laura C. Huang, et al.
Published: (2018-09-01)